AntineoplasticsDrug resistance to osimertinib and savolitinib and diarrhoea: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2017年 / 1643卷 / 1期

关键词：

D O I：

10.1007/s40278-017-27503-y

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：30 / 30

相关论文

共 50 条

[1] AntineoplasticsDrug resistance, diarrhoea and fatigue : case report
[J]. Reactions Weekly, 2024, 2023 (1) : 40 - 40
[2] AntineoplasticsDrug resistance: case report
[J]. Reactions Weekly, 2023, 1945 (1) : 72 - 72
[3] AntineoplasticsDrug resistance: case report
[J]. Reactions Weekly, 2019, 1778 (1) : 54 - 54
[4] Carboplatin/osimertinib/pemetrexedFever, diarrhoea and drug resistance: case report
[J]. Reactions Weekly, 2023, 1970 (1) : 87 - 87
[5] AntineoplasticsDrug resistance: case report
[J]. Reactions Weekly, 2018, 1728 (1) : 49 - 49
[6] AntineoplasticsDrug resistance: case report
[J]. Reactions Weekly, 2022, 1890 (1) : 43 - 43
[7] Brief Report: Heterogeneity of Acquired Resistance Mechanisms to Osimertinib and Savolitinib
Lim, Sun Min
Yang, San-Duk
Lim, Sangbin
Shim, Hyo Sup
Cho, Byoung Chul
[J]. JTO CLINICAL AND RESEARCH REPORTS, 2021, 2 (06):
[8] AntineoplasticsDrug resistance and myelosuppression: case report
[J]. Reactions Weekly, 2022, 1890 (1) : 42 - 42
[9] AntineoplasticsDrug resistance in neuroblastoma: case report
[J]. Reactions Weekly, 2022, 1888 (1) : 50 - 50
[10] Crizotinib/osimertinibDevelopment of resistance to osimertinib in lung adenocarcinoma, rash and diarrhoea: case report
[J]. Reactions Weekly, 2018, 1714 (1) : 131 - 131

← 1 2 3 4 5 →